L. Landais

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology

L Landais, C R Ganellin, J. Schwartz, 2007, Journal of Pharmacology and Experimental Therapeutics.

BF2.649, A NON-IMIDAZOLE INVERSE AGONIST/ANTAGONIST AT THE HUMAN HISTAMINE H3 RECEPTOR: PRECLINICAL PHARMACOLOGY

H. Stark, F. Gbahou, V. Bertaina-Anglade, 2006 .

BF2.649 Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H 3 Receptor: Preclinical Pharmacology

H. Stark, J. Arrang, F. Gbahou, 2006 .

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.

J. Schwartz, J. Arrang, R. Parmentier, 2007, Biochemical pharmacology.

Title Brain histamine and schizophrenia : potential therapeutic applications of H 3-receptor inverse agonists studied with BF 2 . 649

J. Schwartz, J. Arrang, R. Parmentier, 2007 .

Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.

R. Ruffolo, A. Bril, J. Faivre, 1996, The Journal of pharmacology and experimental therapeutics.

Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro‐arrhythmia Assay initiative studies

Gary R. Mirams, J. Schwartz, P. Maison-Blanche, 2017, British journal of pharmacology.

Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.

B. Gout, L. Landais, M. Forest, 1994, Pharmacology.

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.

J. Schwartz, J. Arrang, R. Parmentier, 2007, Biochemical pharmacology.